Now accepting submissions!

Join your community in discussions advancing our understanding of immunological signals, cytokine biology and its role in health and disease

The Society will cover 100% of the article publishing charges on selected manuscripts submitted by April 15th especially for the LAUNCH issue! Please send the title of your manuscript to [email protected] as soon as possible, submissions are due April 15th for consideration of FREE open access article publishing charges.

Signals, the new open access journal of the International Cytokine & Interferon Society (https://signals.biomedcentral.com) is accepting manuscripts. As open access, Signals is free to any reader from any institution or the public and as the Society’s own journal will have increased visibility, especially to the cytokine biology community.

Member of the International Cytokine & Interferon Society will always receive a 20% discount or free open access publication charges depending on the submission. Please contact the Managing Director for more information [email protected].

Our aim with Signals is to create a journal with significant impact in the areas of immunological signals to include cytokines, chemokines and growth factors, signal transduction, microbial and endogenous danger signals. Original studies can be at the levels of basic, translational and clinical research. Signals will publish editorial pieces, letters, interviews and is open to suggestion for other materials of interest to the community. As the official journal of the International Cytokine & Interferon Society, article alerts with links to the full pdf article, will be sent to all members of the Society, so published articles will have immediate exposure to a large international audience dedicated to cytokine and interferon research.

It may take a few years for Signals to attract many papers that are at the level we are aiming for, but we intend to be quite selective. We are excited about this and extremely grateful to the many enthusiastic ICIS supporters who have contributed to its development. We welcome submissions of work that advances the field of immunological signals, cytokine biology and medicine, and we promise timely review by experts.

ICIS Member Discounts and Waivers on article-processing charges (APC)

Signals, the official Open Access journal of the International Cytokine & Interferon Society (ICIS) is a new publication encompassing all aspects of basic, clinical and translational research related to cytokines and will be publishing research articles as well as definitive reviews on cytokines, interleukins, chemokines and growth factors. Committed to advancing the understanding of immunological signals, cytokine biology and its role in health and disease, the journal welcomes manuscripts on all aspects of basic, clinical and translational research related to immunological signals and cytokines. With a rigorous peer review process and a global editorial board, Signals will give your research the high visibility desired within our community. Submit your next manuscript to Signals and receiving an ICIS member 20% discount on the APC if your article is accepted! Please contact the Managing Director for more information [email protected].

Signals is now officially open for new submissions on all on all aspects of basic, clinical and translational research related to cytokines.

We are excited about the potential of Signals to contribute to research and hope to earn your support of this new endeavor.

Reasons to publish with us:

  • Official open access journal owned by the International Cytokine & Interferon Society
  • Encompasses all aspects of basic, clinical and translational research related to cytokines
  • Publishing definitive reviews on cytokines, interleukins, chemokines and growth factors
  • ICIS Member Discounts and Waivers on article-processing charges (APC)

Submit your research to us at: signals.biomedcentral.com

Sign up for article alerts and news on the journal website!

Scott K. Durum, PhD – Editor-in-Chief
Cristina Bergamaschi, PhD – Senior Editor